Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zinc and Probiotics for Rotavirus and Polio Vaccine Response
NCT01616693Phase 4Completed
- Sponsor
- PATH
- Start
- Jul 2012
- Primary completion
- Jul 2013
- Modality
- Small Molecules, Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 4 trial of zinc, Lactobacillus rhamnosus GG in rotavirus infection, poliomyelitis, sponsored by PATH. Started Jul 2012; status: completed.
02
Drugs
zincLactobacillus rhamnosus GG
03
Conditions
rotavirus infectionpoliomyelitis
Beyond the preview
Go deeper on NCT01616693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01616693.